US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

298.92

+2.610.88%

Volume:151.21K

Turnover:44.64M

Market Cap:575.27M

PE:- -

High:299.60

Open:291.05

Low:289.32

Close:296.31

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.64

T/O Rate:7.86%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access

MT Newswires Live

Erasca Wins FDA Fast Track for Pancreatic Therapy

Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and AdaptHealth (AHCO)

Health Care Select Sector SPDR: Pivot points

Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)

Labcorp's Alzheimer's Disease Blood Test Cleared by FDA

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)

Regenxbio reports FDA placed clinical hold on RGX-121

Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease

United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses

MT Newswires Live

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Jill Wu Maintains Buy on Long-Term 707 Growth, Slightly Lowering Target Price to HK$34.78 Amid Near-Term Headwinds

Why Fisher & Paykel Healthcare (NZSE:FPH) Is Back In The Spotlight

Simply Wall St.

First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LABU/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":298.9201,"timestamp":1788284663735,"preClose":296.31,"halted":0,"volume":151214,"delay":0,"changeRate":0.008808680098545404,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Trading","change":2.6101,"latestTime":"09-01 13:44:57 EDT","open":291.05,"high":299.595,"low":289.32,"amount":44639366.27598,"amplitude":0.034677,"askPrice":299.58,"askSize":50,"bidPrice":299.01,"bidSize":50,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.00337,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":287.9,"preClose":296.31,"latestTime":"09:25 EDT","volume":3856,"amount":1113924.82752,"timestamp":1788269101054,"change":-8.41,"changeRate":-0.028382,"amplitude":0.034741},"postHourTrading":{"tag":"盘后","latestPrice":295.02,"preClose":296.31,"latestTime":"19:59 EDT","volume":2518,"amount":745089.4272,"timestamp":1788220773434,"change":-1.29,"changeRate":-0.004354,"amplitude":0.010268},"volumeRatio":0.64163,"impliedVol":0.924,"impliedVolPercentile":0.5595},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.64163,"shares":1924486,"dividePrice":1.0075,"high":299.595,"amplitude":0.034677,"preClose":296.31,"low":289.32,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":298.9201,"eps":0,"divideRate":0.00337,"volume":151214,"delay":0,"ttmEps":0,"open":291.05,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":335.54,"twentyDayClose":249.47,"sixtyDayClose":160.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661927919","title":"Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2661927919","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661927919?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:52","pubTimestamp":1787575979,"startTime":"0","endTime":"0","summary":"Humacyte  said Monday it plans to file in November a supplemental biologics license application with the US Food and Drug Administration to seek approval for the use of its acellular tissue engineered vessel in dialysis access.The company said it will support the filing with data from three phase 3 trials, including a study where female dialysis patients averaged three additional months without a catheter compared with standard of care.The product received regulatory approval in December 2024 for vascular trauma, Humacyte said.Shares of the company were up 6.4% in Monday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4563","BK4585","BK4139","BK4588","HUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727976","title":"Erasca Wins FDA Fast Track for Pancreatic Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727976?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:48","pubTimestamp":1787575690,"startTime":"0","endTime":"0","summary":"Erasca ( ($ERAS) ) has shared an announcement. On August 24, 2026, Erasca, Inc. reported that the U.S. Food and Drug Administration granted Fast Tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ERAS","BK4539","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627930","title":"Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627930","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627930?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575215,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals'  investigational new drug application for the clinical trials of KJ015 for injection was approved by the U.S. Food and Drug Administration.The injection is a subcutaneous formulation of dual epitope-targeting HER2 bispecific antibody, according to a Monday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LABU","02659","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661625279","title":"Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and AdaptHealth (AHCO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661625279","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661625279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on United Therapeutics (UTHR) and AdaptHealth (AHCO) wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-and-adapthealth-ahco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-and-adapthealth-ahco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","BK4137","HCSG","XLV","BK4588","LU1571399168.USD","BK4175","LU1699723380.USD","BK4139","BK4585","LU0029874061.USD","UTHR","XBI","LU0128526141.USD","BK4532","AHCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279560","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279560?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:37","pubTimestamp":1787575027,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $177.02, Pivot Low: $173.21. These were calculated usi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-128?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-128?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4581","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661284276","title":"Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661284276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661284276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:20","pubTimestamp":1787574012,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-natera-ntra-healthequity-hqy-and-cspc-pharmaceutical-group-otherchjtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-natera-ntra-healthequity-hqy-and-cspc-pharmaceutical-group-otherchjtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU2324357040.USD","LU0963586101.USD","LU0029874061.USD","NTRA","BK4137","LU1169590202.USD","BK4588","BK4139","LU0053671581.USD","LU0345770993.USD","LABU","LU2095319765.USD","LU2210149790.SGD","BK4585","BK4154","LU1169589451.USD","GNOM","LU2065171402.SGD","LU1064131342.USD","HCSG","BK4581","LU0012050646.USD","HELX","XBI","LU2065171311.SGD","LU2264538146.SGD","XLV","LU0345770308.USD","LU1988902786.USD","LU0106261612.USD","LU2065170008.USD","LU2065169927.USD","HQY","LU2210150020.SGD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279661","title":"New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279661","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279661?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:15","pubTimestamp":1787573700,"startTime":"0","endTime":"0","summary":"DUBLIN and BRIDGEWATER, N.J., Aug.  24, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today announced","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349705/18362/en/new-analyses-from-reduce-it-and-epa-mechanistic-data-to-be-presented-at-the-european-society-of-cardiology-esc-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4139","BK4090","BK4588","EPV","TG","BK4585","BK4153","AMRN","IPE","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661575279","title":"Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2661575279","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661575279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:03","pubTimestamp":1787572980,"startTime":"0","endTime":"0","summary":"U.S. publication of the patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration with Neurothera Labs Inc. as the FDA intr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349697/0/en/clearmind-advances-mdma-n-acylethanolamines-ip-for-the-treatment-of-ptsd-amid-rising-u-s-federal-support-for-psychedelic-innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","USRD","BK4585","BK4136","CUT","IE00B3T34201.USD","IP","LU1481599808.USD","LU2463526074.USD","LABU","WOOD","BK4588","LU1169589451.USD","LU1481600234.SGD","LU1487256676.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279504","title":"Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279504","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"– Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026 – – Supplemental BLA will be supported by results from three Phase ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349666/0/en/humacyte-confirms-plans-for-atev-supplemental-bla-filing-for-dialysis-access-following-fda-discussions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275904","title":"Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275904?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:40","pubTimestamp":1787571627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Enovis (ENOV) and Aveanna Healthcare Holdings (AVA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z6F94.USD","XBI","XLV","BK4082","ENOV","LABU","BK4539","LU2065732104.USD","BK4588","AVAH","BK4196","BK4581","IE0034390439.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275622","title":"Labcorp's Alzheimer's Disease Blood Test Cleared by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275622","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275622?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:39","pubTimestamp":1787571550,"startTime":"0","endTime":"0","summary":"Labcorp  said Monday that its blood test that detects Alzheimer's disease is now available after receiving clearance from the US Food and Drug Administration.The company said its Elecsys pTau-217 test, developed by Roche Diagnostics, helps identify amyloid pathology associated with Alzheimer's disease in people aged 55 and older with signs, symptoms, or complaints of cognitive decline.The test, according to Labcorp, is the only FDA-cleared single-biomarker blood test to rule in and rule out amyloid pathology in specialty and primary care settings.Labcorp said it expects the test to be available nationwide in the coming months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","LU2237438978.USD","LU1059921491.USD","LU0742534661.SGD","LU0048573561.USD","BK4550","LABU","BK4585","LU0251131958.USD","BK4588","LH","LU0006061336.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275889","title":"Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275889?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Hea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","ELOX","XBI","BK4137","BK4588","CING","LU0029874061.USD","BK4196","BK4585","BK4539","HCSG","AGL","LABU","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627309","title":"Regenxbio reports FDA placed clinical hold on RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627309","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570406,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) provided an update on its investigational gene therapy, RGX-121, for the treatment of Mucopolysaccharidosis type II, also known as...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","RGNX","LABU","SYNB","BK4505","BK4588","LFSC","IBB","BK4585","CNCR","GNOM","BK4563","BK4139","TBXU","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275850","title":"Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275850","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275850?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:16","pubTimestamp":1787570164,"startTime":"0","endTime":"0","summary":"Labcorp (LH) announced it will offer the Elecsys pTau-217 test following clearance by the U.S. FDA. Developed by Roche Diagnostics (RHHBY), the blo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/labcorp-to-offer-elecsys-ptau-217-test-for-alzheimers-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/labcorp-to-offer-elecsys-ptau-217-test-for-alzheimers-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4196","LU0251131958.USD","RHHBY","LH","BK4585","03165","BK4550","HRTS","BK4588","CANC","BK4007","LU0251142724.SGD","LU0742534661.SGD","LU1059921491.USD","LU0048573561.USD","LU0006061336.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273466","title":"United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273466","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273466?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:10","pubTimestamp":1787569843,"startTime":"0","endTime":"0","summary":"United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4131","BK4559","UPS","XLV","LU0029874061.USD","IE00B19Z3B42.SGD","IE00B7KXQ091.USD","BK4585","IE00BFSS8Q28.SGD","LU0320765489.SGD","LU2133065610.SGD","LU2237438978.USD","IYT","UBCP","IE00BJJMRX11.SGD","DOCK","LU1894683264.USD","LU0070302665.USD","SHPP","IE0004445015.USD","LU0496365809.HKD","IE00B19Z3581.USD","XBI","LU0061475181.USD","LU1894683348.USD","LU0149725797.USD","LU1267930227.SGD","BK4581","IE0002270589.USD","LU1162221912.USD","LU0128525689.USD","LABU","SUPL","LU0211331839.USD","LU0320765646.SGD","LU0211326839.USD","LU1430594728.SGD","LU1074936037.SGD","HULL","BK4137","HCSG","UPSG","BK4534","LU0052756011.USD","LU0208291251.USD","LU0310800965.SGD","IE00BJJMRY28.SGD","IE00B7SZLL34.SGD","LU0128526141.USD","LU0211326755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","BK4585","BK4588","PSYK","02659","IBBQ","MDTX","IBBJ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273062","title":"Jill Wu Maintains Buy on Long-Term 707 Growth, Slightly Lowering Target Price to HK$34.78 Amid Near-Term Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273062?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:35","pubTimestamp":1787564142,"startTime":"0","endTime":"0","summary":"3SBio, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jill Wu from CMB International Securities maintained a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jill-wu-maintains-buy-on-long-term-707-growth-slightly-lowering-target-price-to-hk34-78-amid-near-term-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jill-wu-maintains-buy-on-long-term-707-growth-slightly-lowering-target-price-to-hk34-78-amid-near-term-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274331","title":"Why Fisher & Paykel Healthcare (NZSE:FPH) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274331","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661274331?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:27","pubTimestamp":1787563638,"startTime":"0","endTime":"0","summary":"Why Fisher & Paykel Healthcare guidance matters now\nFisher & Paykel Healthcare (NZSE:FPH) drew investor attention on 20 August 2026 after updating its outlook for the 2027 financial year, with higher full year earnings guidance and fresh expectations for the first half.\nSee our latest analysis for Fisher & Paykel Healthcare.\nThe guidance upgrade on 20 August 2026 comes after a strong run in Fisher & Paykel Healthcare shares, with a 12.18% 1 month share price return, a 20.39% 3 month share...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/why-fisher-paykel-healthcare-nzsefph-is-back-in-the-spotligh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/why-fisher-paykel-healthcare-nzsefph-is-back-in-the-spotligh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","FPH.NZ","BK8004","LABU","FPH","XBI","BK4588","BK4585","BK4193","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661022177","title":"First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2661022177","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661022177?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:00","pubTimestamp":1787558400,"startTime":"0","endTime":"0","summary":"The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough The","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349489/0/en/first-patient-treated-in-pioneer-1-registrational-trial-of-privosegtor-for-optic-neuritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU0795875086.SGD","IE00B775SV38.USD","LU1978683503.SGD","LU2028103732.USD","LU0724618433.USD","LU0098860793.USD","LU1074936037.SGD","LU1854103824.USD","LU2298322129.HKD","BK4581","BK4081","LU2347655156.SGD","LU1244550221.USD","KBWB","LU0882574139.USD","LU0267386448.USD","BK4127","LU0528227936.USD","LU1732800096.USD","IE00B3S45H60.SGD","IAI","LU1244550494.USD","BK4141","LU1791710582.SGD","LU1732799900.SGD","BK4504","BK4588","EMA","LU0912757837.SGD","IE00BD6J9T35.USD","IE00BZ199S13.USD","LU0225283273.USD","LU2089284900.SGD","LU0348723411.USD","LU1720051017.SGD","LU1861220033.SGD","LU0158827948.USD","LU1668664300.SGD","LU0390134368.USD","IE00BZ1G4Q59.USD","ONG","LU0106261372.USD","LU2089283258.USD","ON","LU0234570918.USD","LABU","ONX","LU1983260115.SGD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226346","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226346?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rani Therapeutics Holdings (RANI) and Sanofi (SNYNF)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XBI","BK4007","XLV","HCSG","BK4585","RANI","BK4581","SNYNF","BK4137","BK4539","LU0128526141.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":14,"totalSize":406,"code":"91000000","status":"200"}]}}